Global Somatostatin for Injection Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

Report ID: GIR2210030013 | Category: Pharma & Healthcare | Pages: 112 | Format: PDF | Published Date: October 27,2022

Request Sample Enquiry before buying Ask For Discount

Single User-$3480.00 Multi User-$5220.00

Report Description
View Table of Contents

Report Summary

Somatostatin for injection is a synthetic cyclic fourteen amino acid, which is exactly the same as natural growth hormone in chemical structure and action. By intravenous injection, somatostatin inhibits the secretion of growth hormone, thyroid-stimulating hormone, insulin, and glucagon, and suppresses the secretion of gastric acid. It also affects absorption, motility, splanchnic blood flow, and nutritional function of the gastrointestinal tract.
According to our (Global Info Research) latest study, the global Somatostatin for Injection market size was valued at USD million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
This report is a detailed and comprehensive analysis for global Somatostatin for Injection market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2022, are provided.
Key Features:
Global Somatostatin for Injection market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2017-2028
Global Somatostatin for Injection market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2017-2028
Global Somatostatin for Injection market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2017-2028
Global Somatostatin for Injection market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2017-2022
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Somatostatin for Injection
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Somatostatin for Injection market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Biocon, Ferring Pharmaceuticals, Serum Institute of India, UCB India Private Limited and Eumedica, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Somatostatin for Injection market is split by Type and by Application. For the period 2017-2028, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
    1mg/Vial
    3mg/Vial
    Others
Market segment by Application
    Hospital
    Clinic
Major players covered
    Biocon
    Ferring Pharmaceuticals
    Serum Institute of India
    UCB India Private Limited
    Eumedica
    Merck
    Sanofi
    PolyPeptide Group
    Samarth Life Sciences Pvt
    Hybio Pharmaceutical
    Yangtze River Pharmaceutical
    Hainan Shuangcheng Pharmaceuticals
    Hainan Zhonghe Pharmaceutical
    Wuhan Hualong
    Qingdao Guoda
    Chengdu Shengnuo
    Kumming Longjin Pharmaceutical
Market segment by region, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Somatostatin for Injection product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Somatostatin for Injection, with price, sales, revenue and global market share of Somatostatin for Injection from 2017 to 2022.
Chapter 3, the Somatostatin for Injection competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Somatostatin for Injection breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Somatostatin for Injection market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Somatostatin for Injection.
Chapter 14 and 15, to describe Somatostatin for Injection sales channel, distributors, customers, research findings and conclusion.

1 Market Overview
    1.1 Somatostatin for Injection Introduction
    1.2 Market Estimation Caveats and Base Year
    1.3 Market Analysis by Type
        1.3.1 Overview: Global Somatostatin for Injection Consumption Value by Type: 2017 Versus 2021 Versus 2028
        1.3.2 1mg/Vial
        1.3.3 3mg/Vial
        1.3.4 Others
    1.4 Market Analysis by Application
        1.4.1 Overview: Global Somatostatin for Injection Consumption Value by Application: 2017 Versus 2021 Versus 2028
        1.4.2 Hospital
        1.4.3 Clinic
    1.5 Global Somatostatin for Injection Market Size & Forecast
        1.5.1 Global Somatostatin for Injection Consumption Value (2017 & 2021 & 2028)
        1.5.2 Global Somatostatin for Injection Sales Quantity (2017-2028)
        1.5.3 Global Somatostatin for Injection Average Price (2017-2028) 
2 Manufacturers Profiles
    2.1 Biocon
        2.1.1 Biocon Details
        2.1.2 Biocon Major Business
        2.1.3 Biocon Somatostatin for Injection Product and Services
        2.1.4 Biocon Somatostatin for Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2017-2022)
        2.1.5 Biocon Recent Developments/Updates
    2.2 Ferring Pharmaceuticals
        2.2.1 Ferring Pharmaceuticals Details
        2.2.2 Ferring Pharmaceuticals Major Business
        2.2.3 Ferring Pharmaceuticals Somatostatin for Injection Product and Services
        2.2.4 Ferring Pharmaceuticals Somatostatin for Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2017-2022)
        2.2.5 Ferring Pharmaceuticals Recent Developments/Updates
    2.3 Serum Institute of India
        2.3.1 Serum Institute of India Details
        2.3.2 Serum Institute of India Major Business
        2.3.3 Serum Institute of India Somatostatin for Injection Product and Services
        2.3.4 Serum Institute of India Somatostatin for Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2017-2022)
        2.3.5 Serum Institute of India Recent Developments/Updates
    2.4 UCB India Private Limited
        2.4.1 UCB India Private Limited Details
        2.4.2 UCB India Private Limited Major Business
        2.4.3 UCB India Private Limited Somatostatin for Injection Product and Services
        2.4.4 UCB India Private Limited Somatostatin for Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2017-2022)
        2.4.5 UCB India Private Limited Recent Developments/Updates
    2.5 Eumedica
        2.5.1 Eumedica Details
        2.5.2 Eumedica Major Business
        2.5.3 Eumedica Somatostatin for Injection Product and Services
        2.5.4 Eumedica Somatostatin for Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2017-2022)
        2.5.5 Eumedica Recent Developments/Updates
    2.6 Merck
        2.6.1 Merck Details
        2.6.2 Merck Major Business
        2.6.3 Merck Somatostatin for Injection Product and Services
        2.6.4 Merck Somatostatin for Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2017-2022)
        2.6.5 Merck Recent Developments/Updates
    2.7 Sanofi
        2.7.1 Sanofi Details
        2.7.2 Sanofi Major Business
        2.7.3 Sanofi Somatostatin for Injection Product and Services
        2.7.4 Sanofi Somatostatin for Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2017-2022)
        2.7.5 Sanofi Recent Developments/Updates
    2.8 PolyPeptide Group
        2.8.1 PolyPeptide Group Details
        2.8.2 PolyPeptide Group Major Business
        2.8.3 PolyPeptide Group Somatostatin for Injection Product and Services
        2.8.4 PolyPeptide Group Somatostatin for Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2017-2022)
        2.8.5 PolyPeptide Group Recent Developments/Updates
    2.9 Samarth Life Sciences Pvt
        2.9.1 Samarth Life Sciences Pvt Details
        2.9.2 Samarth Life Sciences Pvt Major Business
        2.9.3 Samarth Life Sciences Pvt Somatostatin for Injection Product and Services
        2.9.4 Samarth Life Sciences Pvt Somatostatin for Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2017-2022)
        2.9.5 Samarth Life Sciences Pvt Recent Developments/Updates
    2.10 Hybio Pharmaceutical
        2.10.1 Hybio Pharmaceutical Details
        2.10.2 Hybio Pharmaceutical Major Business
        2.10.3 Hybio Pharmaceutical Somatostatin for Injection Product and Services
        2.10.4 Hybio Pharmaceutical Somatostatin for Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2017-2022)
        2.10.5 Hybio Pharmaceutical Recent Developments/Updates
    2.11 Yangtze River Pharmaceutical
        2.11.1 Yangtze River Pharmaceutical Details
        2.11.2 Yangtze River Pharmaceutical Major Business
        2.11.3 Yangtze River Pharmaceutical Somatostatin for Injection Product and Services
        2.11.4 Yangtze River Pharmaceutical Somatostatin for Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2017-2022)
        2.11.5 Yangtze River Pharmaceutical Recent Developments/Updates
    2.12 Hainan Shuangcheng Pharmaceuticals
        2.12.1 Hainan Shuangcheng Pharmaceuticals Details
        2.12.2 Hainan Shuangcheng Pharmaceuticals Major Business
        2.12.3 Hainan Shuangcheng Pharmaceuticals Somatostatin for Injection Product and Services
        2.12.4 Hainan Shuangcheng Pharmaceuticals Somatostatin for Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2017-2022)
        2.12.5 Hainan Shuangcheng Pharmaceuticals Recent Developments/Updates
    2.13 Hainan Zhonghe Pharmaceutical
        2.13.1 Hainan Zhonghe Pharmaceutical Details
        2.13.2 Hainan Zhonghe Pharmaceutical Major Business
        2.13.3 Hainan Zhonghe Pharmaceutical Somatostatin for Injection Product and Services
        2.13.4 Hainan Zhonghe Pharmaceutical Somatostatin for Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2017-2022)
        2.13.5 Hainan Zhonghe Pharmaceutical Recent Developments/Updates
    2.14 Wuhan Hualong
        2.14.1 Wuhan Hualong Details
        2.14.2 Wuhan Hualong Major Business
        2.14.3 Wuhan Hualong Somatostatin for Injection Product and Services
        2.14.4 Wuhan Hualong Somatostatin for Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2017-2022)
        2.14.5 Wuhan Hualong Recent Developments/Updates
    2.15 Qingdao Guoda
        2.15.1 Qingdao Guoda Details
        2.15.2 Qingdao Guoda Major Business
        2.15.3 Qingdao Guoda Somatostatin for Injection Product and Services
        2.15.4 Qingdao Guoda Somatostatin for Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2017-2022)
        2.15.5 Qingdao Guoda Recent Developments/Updates
    2.16 Chengdu Shengnuo
        2.16.1 Chengdu Shengnuo Details
        2.16.2 Chengdu Shengnuo Major Business
        2.16.3 Chengdu Shengnuo Somatostatin for Injection Product and Services
        2.16.4 Chengdu Shengnuo Somatostatin for Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2017-2022)
        2.16.5 Chengdu Shengnuo Recent Developments/Updates
    2.17 Kumming Longjin Pharmaceutical
        2.17.1 Kumming Longjin Pharmaceutical Details
        2.17.2 Kumming Longjin Pharmaceutical Major Business
        2.17.3 Kumming Longjin Pharmaceutical Somatostatin for Injection Product and Services
        2.17.4 Kumming Longjin Pharmaceutical Somatostatin for Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2017-2022)
        2.17.5 Kumming Longjin Pharmaceutical Recent Developments/Updates
3 Competitive Environment: Somatostatin for Injection by Manufacturer
    3.1 Global Somatostatin for Injection Sales Quantity by Manufacturer (2017-2022)
    3.2 Global Somatostatin for Injection Revenue by Manufacturer (2017-2022)
    3.3 Global Somatostatin for Injection Average Price by Manufacturer (2017-2022)
    3.4 Market Share Analysis (2021)
        3.4.1 Producer Shipments of Somatostatin for Injection by Manufacturer Revenue ($MM) and Market Share (%): 2021
        3.4.2 Top 3 Somatostatin for Injection Manufacturer Market Share in 2021
        3.4.2 Top 6 Somatostatin for Injection Manufacturer Market Share in 2021
    3.5 Somatostatin for Injection Market: Overall Company Footprint Analysis
        3.5.1 Somatostatin for Injection Market: Region Footprint
        3.5.2 Somatostatin for Injection Market: Company Product Type Footprint
        3.5.3 Somatostatin for Injection Market: Company Product Application Footprint
    3.6 New Market Entrants and Barriers to Market Entry
    3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
    4.1 Global Somatostatin for Injection Market Size by Region
        4.1.1 Global Somatostatin for Injection Sales Quantity by Region (2017-2028)
        4.1.2 Global Somatostatin for Injection Consumption Value by Region (2017-2028)
        4.1.3 Global Somatostatin for Injection Average Price by Region (2017-2028)
    4.2 North America Somatostatin for Injection Consumption Value (2017-2028)
    4.3 Europe Somatostatin for Injection Consumption Value (2017-2028)
    4.4 Asia-Pacific Somatostatin for Injection Consumption Value (2017-2028)
    4.5 South America Somatostatin for Injection Consumption Value (2017-2028)
    4.6 Middle East and Africa Somatostatin for Injection Consumption Value (2017-2028)
5 Market Segment by Type
    5.1 Global Somatostatin for Injection Sales Quantity by Type (2017-2028)
    5.2 Global Somatostatin for Injection Consumption Value by Type (2017-2028)
    5.3 Global Somatostatin for Injection Average Price by Type (2017-2028)
6 Market Segment by Application
    6.1 Global Somatostatin for Injection Sales Quantity by Application (2017-2028)
    6.2 Global Somatostatin for Injection Consumption Value by Application (2017-2028)
    6.3 Global Somatostatin for Injection Average Price by Application (2017-2028)
7 North America
    7.1 North America Somatostatin for Injection Sales Quantity by Type (2017-2028)
    7.2 North America Somatostatin for Injection Sales Quantity by Application (2017-2028)
    7.3 North America Somatostatin for Injection Market Size by Country
        7.3.1 North America Somatostatin for Injection Sales Quantity by Country (2017-2028)
        7.3.2 North America Somatostatin for Injection Consumption Value by Country (2017-2028)
        7.3.3 United States Market Size and Forecast (2017-2028)
        7.3.4 Canada Market Size and Forecast (2017-2028)
        7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe
    8.1 Europe Somatostatin for Injection Sales Quantity by Type (2017-2028)
    8.2 Europe Somatostatin for Injection Sales Quantity by Application (2017-2028)
    8.3 Europe Somatostatin for Injection Market Size by Country
        8.3.1 Europe Somatostatin for Injection Sales Quantity by Country (2017-2028)
        8.3.2 Europe Somatostatin for Injection Consumption Value by Country (2017-2028)
        8.3.3 Germany Market Size and Forecast (2017-2028)
        8.3.4 France Market Size and Forecast (2017-2028)
        8.3.5 United Kingdom Market Size and Forecast (2017-2028)
        8.3.6 Russia Market Size and Forecast (2017-2028)
        8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific
    9.1 Asia-Pacific Somatostatin for Injection Sales Quantity by Type (2017-2028)
    9.2 Asia-Pacific Somatostatin for Injection Sales Quantity by Application (2017-2028)
    9.3 Asia-Pacific Somatostatin for Injection Market Size by Region
        9.3.1 Asia-Pacific Somatostatin for Injection Sales Quantity by Region (2017-2028)
        9.3.2 Asia-Pacific Somatostatin for Injection Consumption Value by Region (2017-2028)
        9.3.3 China Market Size and Forecast (2017-2028)
        9.3.4 Japan Market Size and Forecast (2017-2028)
        9.3.5 Korea Market Size and Forecast (2017-2028)
        9.3.6 India Market Size and Forecast (2017-2028)
        9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
        9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America
    10.1 South America Somatostatin for Injection Sales Quantity by Type (2017-2028)
    10.2 South America Somatostatin for Injection Sales Quantity by Application (2017-2028)
    10.3 South America Somatostatin for Injection Market Size by Country
        10.3.1 South America Somatostatin for Injection Sales Quantity by Country (2017-2028)
        10.3.2 South America Somatostatin for Injection Consumption Value by Country (2017-2028)
        10.3.3 Brazil Market Size and Forecast (2017-2028)
        10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa
    11.1 Middle East & Africa Somatostatin for Injection Sales Quantity by Type (2017-2028)
    11.2 Middle East & Africa Somatostatin for Injection Sales Quantity by Application (2017-2028)
    11.3 Middle East & Africa Somatostatin for Injection Market Size by Country
        11.3.1 Middle East & Africa Somatostatin for Injection Sales Quantity by Country (2017-2028)
        11.3.2 Middle East & Africa Somatostatin for Injection Consumption Value by Country (2017-2028)
        11.3.3 Turkey Market Size and Forecast (2017-2028)
        11.3.4 Egypt Market Size and Forecast (2017-2028)
        11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
        11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Market Dynamics
    12.1 Somatostatin for Injection Market Drivers
    12.2 Somatostatin for Injection Market Restraints
    12.3 Somatostatin for Injection Trends Analysis
    12.4 Porters Five Forces Analysis
        12.4.1 Threat of New Entrants
        12.4.2 Bargaining Power of Suppliers
        12.4.3 Bargaining Power of Buyers
        12.4.4 Threat of Substitutes
        12.4.5 Competitive Rivalry
    12.5 Influence of COVID-19 and Russia-Ukraine War
        12.5.1 Influence of COVID-19
        12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
    13.1 Raw Material of Somatostatin for Injection and Key Manufacturers
    13.2 Manufacturing Costs Percentage of Somatostatin for Injection
    13.3 Somatostatin for Injection Production Process
    13.4 Somatostatin for Injection Industrial Chain
14 Shipments by Distribution Channel
    14.1 Sales Channel
        14.1.1 Direct to End-User
        14.1.2 Distributors
    14.2 Somatostatin for Injection Typical Distributors
    14.3 Somatostatin for Injection Typical Customers
15 Research Findings and Conclusion
16 Appendix
    16.1 Methodology
    16.2 Research Process and Data Source
    16.3 Disclaimer

FAQ's

What does the report cover (Scope)?

It contains all the geographic trends, and market analysis for global market

ENTER REPORT NAME TO SEARCH

Global Somatostatin for Injection Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

Report Summary

Table of Contents

FAQ's

What does the report cover (Scope)?